Learning From Trials on Radiation Dose in Non-Small Cell Lung Cancer

Jeffrey Bradley, Chen Hu

Research output: Contribution to journalReview article

Abstract

In this issue of the International Journal of Radiation Oncology • Biology • Physics, Taylor et al present a meta-analysis of published data supporting 2 findings: (1) radiation dose escalation seems to benefit patients who receive radiation alone for non-small cell lung cancer; and (2) radiation dose escalation has a detrimental effect on overall survival in the setting of concurrent chemotherapy. The latter finding is supported by data but has perplexed the oncology community. Perhaps these findings are not perplexing at all. Perhaps it is simply another lesson in the major principle in radiation oncology, to minimize radiation dose to normal tissues.

Original languageEnglish (US)
Pages (from-to)748-750
Number of pages3
JournalInternational Journal of Radiation Oncology Biology Physics
Volume96
Issue number4
DOIs
StatePublished - Nov 15 2016

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'Learning From Trials on Radiation Dose in Non-Small Cell Lung Cancer'. Together they form a unique fingerprint.

  • Cite this